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Abstract
Background: The initial vanguard cohort of the U.S. National Children’s Study was a pregnancy and birth cohort
study that sought to enroll some women prior to pregnancy, and to assess exposures early in pregnancy.
Methods: During the recruitment phase (2009–2010), geographically based sampling was used to recruit women early
in pregnancy and women not currently pregnant, not using contraception and heterosexually active. We assessed the
following outcomes for women enrolled preconception and early in pregnancy: yield of births; demographic
characteristics of births for different enrollment groups; time to pregnancy for preconception women; and the
timing of study visits for exposure assessment.
Results: 1399 women were recruited into the initial vanguard cohort: 429 preconception (198 trying for pregnancy, and
231 not trying) and 970 already pregnant. There were 1135 pregnancies (81 % of women) and 922 newborns enrolled
(81 % of pregnancies) through September 2012. Preconception women represented 30.6 % of women enrolled, and
contributed 14.5 % of births. Among women who gave birth, and who had enrolled preconception trying for
pregnancy, 67.3 % were white non-Hispanic, compared to 50.0 % of preconception women not trying for pregnancy,
and 61.5 % of pregnant women. Women enrolled preconception who were trying for pregnancy had higher cumulative
probability of pregnancy at one year compared to women not trying (adjusted 86 % versus 56 %). Of 165 women
enrolled preconception who became pregnant, 19 % had a study visit within 30 days of conception. By 10.5 weeks after
conception, 75 % of women enrolled preconception had completed a pregnancy study visit; for women enrolled
pregnant, the 75 % threshold was reached at 28.4 weeks.
Conclusions: There were demographic differences in births from women enrolled preconception trying for pregnancy,
preconception not trying for pregnancy, or during pregnancy. Time to pregnancy was shorter for women actively trying
for pregnancy. Most women enrolled preconception did not have exposure assessment within 30 days of conception,
but they did have exposure assessment much earlier during pregnancy than women who enrolled during pregnancy.
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Background
The United States National Children’s Study (NCS) was
planned as a longitudinal study designed to examine ef-
fects of environmental exposures on children’s health
[1]. As defined by the NCS, “environment” is conceived
broadly to include chemical, physical, psychosocial, and
biological exposures as well as gene environment inter-
actions and epigenetic influences. The NCS used a prob-
ability sampling scheme designed to be representative of
the United States population [2, 3]. The study has now
been discontinued, but data from its initial phases are
available for analysis [4].
The NCS began with a pilot or vanguard phase, starting
with seven Initial Vanguard Centers, with later expansion
to add 33 more Vanguard Centers. The purpose of the ini-
tial vanguard cohort of the NCS has been to develop and
pilot test methods to be used in the NCS, with emphasis
on feasibility, acceptability, and costs of recruitment, logis-
tics, and study visit assessments [1, 5, 6].
In the initial planning stages of the NCS, some of the
proposed innovations of the NCS relative to other birth
cohorts included 1) rigorous population-representative
sampling, 2) very detailed assessments of environmental
exposure, and 3) preconception and early pregnancy en-
rollment for more timely and accurate exposure assess-
ment around conception (fertilization) and the early
critical windows of embryonic and fetal development [7].
All of these features were emphasized in the initial van-
guard cohort of the NCS; the third point is the main
focus of this paper.
To meet the scientific objective of prospective assess-
ment of periconception, embryonic, and early fetal expos-
ure, the initial vanguard cohort of the NCS was designed
to enroll women as early in pregnancy as possible, and
also to enroll some women who were not currently preg-
nant, but heterosexually active and at high probability of
becoming pregnant in the near future [8]. A number of
questions arose about the impact of preconception re-
cruitment, including the yield of births, and the potential
for selection bias from recruiting women who self-identify
as trying for pregnancy, and the potential for timely com-
pletion of exposure assessments, particularly preceding
and/or following the estimated time of conception [9, 10].
In this paper, we use data assembled by the seven Initial
Vanguard Centers (recruited in 2009–2010) to assess the
impact of preconception and early pregnancy recruitment
in the initial vanguard cohort of the National Children’s
Study on the following study outcomes:
1. Yield of births in the study from women enrolled
preconception and during early pregnancy, assessing
efficiency for births enrolled.
2. Demographic characteristics of births from women
enrolled preconception and during early pregnancy,
assessing representativeness of the different types of
enrollment. This included two subtypes of women at
high probability of pregnancy: those who self-
identified as “trying” to become pregnant and those
who were not “trying” for pregnancy but still at be-
havioral risk of pregnancy.
3. Time to pregnancy for women identified on initial
population screening as having high probability of
pregnancy in the near future (including both
subtypes), assessing time required for preconception
recruitment.
4. Time from first study visit to conception for women
enrolled preconception, assessing timeliness of
preconception exposure assessment.
5. Time from conception to the next study visit (which
could be the first study visit) for all women in the




Details of the initial sampling strategy for the NCS have
been previously reported [3, 11]. Briefly, 105 primary sam-
pling units (PSUs) were identified involving 110 counties.
Subsequently, 7 Initial Vanguard Centers were chosen to
implement the initial vanguard cohort of the NCS in 7
PSUs: the Mount Sinai School of Medicine (Queens
County, NY), the Children’s Hospital of Philadelphia
(Montgomery County, PA), the University of Wisconsin
(Waukesha County, WI), South Dakota State University
(Brookings County SD, Yellow Medicine County MN,
Pipestone County MN and Lincoln County MN), the
University of California at Irvine (Orange County, CA),
University of Utah (Salt Lake County, UT), and the
University of North Carolina at Chapel Hill (Duplin
County, NC). Within each PSU, smaller geographic areas
(termed segments) were selected as the secondary sam-
pling units (SSU), using a stratified random sampling
scheme.
Timeline
A timeline of key events related to study enrollment,
changes in eligibility for enrollment, and other events re-
lated to this analysis is given in Fig. 1. Each of the events
noted there is described in more detail below.
Enumeration, eligibility screening and enrollment
Enumeration, screening for eligibility and enrollment
began in January 2009 for two Initial Vanguard Centers,
and was implemented in all seven Initial Vanguard Centers
by May 2009, as has been described in detail previously
[11]. The primary means of identifying and recruiting eli-
gible women was based on contact at residences within
each SSU. Data collectors went door to door to each
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household and enumerated all persons living in the house-
hold, based on one adult informant.
Women of reproductive age living in the household
were screened for eligibility via a “pregnancy screener.”
The pregnancy screener included a computer-assisted self
interview with audio that asked questions addressing preg-
nancy, sexual activity, use of birth control, and medical
history of infertility or sterility. Initially, only pregnant
women who were within the first 20 weeks of pregnancy
and residing in a SSU were eligible for inclusion in the
study; after approximately 6 months from when each in-
dividual SSU began enrollment any pregnant woman
residing in that SSU became eligible. Based on local IRB
requirements, some Initial Vanguard Centers enrolled
pregnant women under age 18, and some did not.
The initial enumeration of all geographically eligible
households lasted approximately 6–8 months, with
some variability among the Initial Vanguard Centers.
Both concurrently and subsequently, other awareness
and recruitment activities were implemented to identify
new households and new women moving into estab-
lished households, as well as strategies to promote the
self-identification of newly eligible women to NCS staff,
including promotion of the study at clinics, community
outreach activities and referral from study participants.
The precise mix of activities varied according to local
circumstances of the Initial Vanguard Centers.
Women who were not pregnant, and who were not ster-
ile were asked for permission to be followed with periodic
telephone calls. These women were classified as having
high, moderate, or low probability of pregnancy, with the
frequency of the follow-up calls varying according to their
expected probability of becoming pregnant, as described in
more detail elsewhere [11]. Women were classified as “high
probability of pregnancy” if they were age 18–44, not cur-
rently pregnant, and trying to get pregnant for less than
5 months, i.e., “high tryers.” Women who were age 18–34
years, heterosexually active (within the past 3 months), and
not using any birth control method (other than withdrawal
or natural family planning) were classified as “high non-
tryers”. Both of these groups were contacted one, two, and
four months after being so identified. Starting in June 2010
(up to November 2010 for some centers), the follow-up
telephone pregnancy screener was simplified to remove
any questions about birth control use or sexual activity,
and women were eligible for preconception enrollment
only if they indicated they were currently trying to become
pregnant for less than 5 months (i.e., high non-tryers were
no longer identified or offered preconception enrollment).
Women classified as having a moderate probability of
Fig. 1 Key events and changes in eligibility during the enrollment period for the initial vanguard centers of the National Children’s Study
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pregnancy were called every 3 months, and women classi-
fied as having a low probability of pregnancy were con-
tacted in 6 months. Women who were identified at a
follow-up telephone call as eligible (pregnant or newly at
high probability of pregnancy) were recruited for the
study.
Informed consent was obtained in person from precon-
ception and pregnant women for their participation in the
study. During the third trimester, or at the time of birth,
an additional informed consent was obtained to allow the
infant to continue in the study. The initial vanguard study
protocol and all subsequent amendments were approved
by the Eunice Kennedy Shriver National Institute of Child
Health and Human Development (NICHD) Institutional
Review Board (protocol # 09-CH-N083), and local
Institutional Review Boards at each of the participating
Initial Vanguard Centers: the Icahn School of Medicine
at Mount Sinai Institutional Review Board; the Children’s
Hospital of Philadelphia Research Institute Committee for
the Protection of Human Subjects (IRB); the University of
Wisconsin-Madison Health Sciences Institutional Review
Board; South Dakota State University Human Subjects
Research Committee; Institutional Review Board A,
Human Research Protection Program, Office of Research
Administration, University of California, Irvine; the
University of Utah Institutional Review Board; the Non-
Biomedical Institutional Review Board at the University of
North Carolina, Chapel Hill.
Preconception enrollment
While enrollment of pregnant women began in January-
May 2009, preconception enrollment was begun in
January 2010. Women identified as high-tryers or high
non-tryers were eligible for preconception enrollment
and data collection. After 4 months in either high prob-
ability group without pregnancy, women were transi-
tioned to a moderate probability group and were no
longer eligible for preconception enrollment (but still
eligible for pregnancy enrollment).
Restriction of recruitment and transition to retention
Recruitment and enrollment continued through September
2010. Thereafter, the protocol was streamlined con-
siderably; during this time new recruitment was de-
emphasized and ultimately phased out for the Initial
Vanguard Centers. Although some women ultimately
enrolled more than one child in the NCS, only first
pregnancies of the women in the initial vanguard co-
hort are included in this analysis. The closing date
for the data set used for this analysis is September
2012. We are aware of 9 additional births to this co-
hort after that date that are not included in this data
set.
Identification of the estimated date of conception and
time to pregnancy
The estimated date of delivery, or “due date,” was taken
from ultrasound records. The study protocol specified
that one ultrasound should be done in each trimester.
Some of these ultrasounds were done by the study, and
some were done as part of clinical care; in the latter
case, clinical ultrasound reports were obtained and data
were abstracted. The earliest ultrasound available was
used for determining the estimated date of delivery. The
estimated date of conception (fertilization) was calcu-
lated as the date exactly 38 weeks prior to the due date.
Study home visits
Following informed consent, separate home visits were
scheduled for the initial data collection. The schedule of
home visits in the study included preconception visits,
first trimester visits, and third trimester visits. The stage
in her pregnancy when a woman consented (e.g., pre-
conception, first trimester, or later) determined which of
these would be her first study visit; she was then eligible
for all subsequent visits on the study schedule. Each of
these home visits lasted approximately 3 h to complete
all interview, anthropometric, biological and environ-
mental assessments. The study also included separate
ultrasound visits, birth visits (in the hospital or at home),
subsequent newborn visits, and telephone contacts
about the newborn; but these visits are not considered
in the scope of this paper.
Additional details of the design of the initial vanguard
cohort of the NCS have been reviewed elsewhere [11, 12].
Statistical analysis
We calculated descriptive statistics to describe the pro-
portions of participants conceiving and giving birth, and
to summarize their demographic characteristics. We ex-
amined the distributions of the following time intervals:
1) time from screening to pregnancy for women found
to be at high probability of pregnancy at initial screening,
2) time from the preconception visit to conception for
women enrolled preconception, and 3) time from concep-
tion to the first study visit for all women in the study. For
time from screening and time from conception to the first
study visit, we employed survival analysis to account for
those exiting from follow up (due to moving, loss to follow
up, pregnancy loss, or withdrawal). Also censored in the
analysis of time to first home study visit are those still
awaiting a visit at the point of transition to a new study
data system after September 2010, since we did not have
data on visits available from that system. For some ana-
lyses, we excluded a small number of participants who had
date inconsistencies that could not be resolved with avail-
able data (for example, a pregnancy home visit that oc-
curred more than a year after the date of conception).
Stanford et al. BMC Medical Research Methodology  (2015) 15:75 Page 4 of 11
Results
Yield and retention
From the beginning of enrollment (January 2009 through
May 2009 for the different Initial Vanguard Centers)
through September 2010, 30,062 women were screened,
of whom 744 were pregnant at the time of screening, and
23,608 were eligible for telephone follow-up based on
their geographic residence, age and reproductive potential.
Among these women, 831 became pregnant (and eligible)
during the follow-up recruitment period, and 861 became
eligible because of transitioning to a high probability of
conceiving. Ultimately, 1399 women were enrolled into
the initial vanguard cohort, representing 61 % of the
women found eligible for the study. Details of screening,
eligibility, and enrollment of all women screened for the
study have been reported previously [11]. Table 1 sum-
marizes the proportion of preconception women and
pregnant women enrolled in the study, and the resulting
births. Preconception women represented 30.6 % of the
women consented for the study, but contributed 15.4 %
of the pregnancies and births in the study. Pregnancy
loss was documented for 34 women (3.0 % of pregnan-
cies overall); however, we believe that there were add-
itional pregnancy losses that were lost to follow-up, for
reasons described in the discussion. Among the 1399
women enrolled in the study, we had missing informa-
tion for 0 (0 %) for date of birth, and 66 (4.7 %) for race
or ethnicity.
Of all women who were pregnant and enrolled in
the initial vanguard cohort, 81.2 % had a birth with
an infant identified by the study. All but 21 (2.2 %)
of the 922 births identified in the study follow-up
had documented consent to continue in the study.
The earliest study birth occurred in July 2009, and
the latest study birth in this data set occurred in Sep-
tember 2012. Of the 922 births in the initial van-
guard cohort, 11 % occurred in 2009, 64 % in 2010,
18 % in 2011, and 2 % in 2012, with 5 % having an
unknown date of birth.
Demographic characteristics by type of eligibility
at consent
Table 2 depicts maternal age and race/ethnicity distribu-
tions among NCS births, in relation to the eligibility sta-
tus at the time of consent. We note that women under
18 years of age were eligible for enrollment for the NCS
only if they were already pregnant. However, because
some cell counts are too small they are not displayed in
accordance with NCS non-disclosure policy. High tryers
were less likely to be Hispanic. There were no high
tryers ages 18–19. Despite age eligibility restriction,
there were some high non-tryers who were 35 or older
(albeit too few to display). High non-tryers were much
less likely to be white, non-Hispanic than either high
tryers or pregnant women.
Time to pregnancy among preconception women
We assessed time to pregnancy for all the women identi-
fied as preconception eligible at screening. (Many of these
women did not actually enroll preconception, but rather
enrolled when they were already pregnant, because their
screening happened prior to the implementation of the
preconception part of the study in January 2010.) Of the
1399 women who ultimately enrolled, 403 women were
identified at the time of initial screening as eligible for pre-
conception enrollment (215 high non-tryers, and 188
tryers). Of these women, 16 high non-tryers and 23 high
tryers subsequently had an estimated date of conception
determined that was on or prior to the date of screening
(i.e., they were actually pregnant at screening although not
identified as such), and these are excluded from the follow-
ing analysis, as are the 4 women for whom an estimated
date of conception was not recorded. The crude probability
of conception at 365 days was 45 % (+/− standard devi-
ation 3.5 %) for high non-tryers and 76 % (+/− 3.5 %)
for high tryers. The probability of conception adjusted
for loss to follow-up, shown in Fig. 2, was about 56 %
(+/− 4.0 %) for high non-tryers and 86 % (+/− 2.9 %) for
high tryers at one year, respectively. The difference in
Table 1 Enrollment, pregnancy, and births by eligibility status at initial consent
High non-tryer High tryer Total preconception Pregnant Total
Number of women consented 231 198 429 970 1399
Proportion of women consented in study 16.5 % 14.2 % 30.6 % 69.3 % 100.0 %
Number of pregnancies 54 111 165 970 1135
Proportion of women conceiving 23.4 % 56.1 % 38.5 % 100.0 % 81.1 %
Proportion of pregnancies in study 4.8 % 9.8 % 14.5 % 85.5 % 100.0 %
Number of women giving birth 44 98 142 780 922
Proportion of pregnant women with known birth 81.5 % 88.3 % 86.1 % 80.4 % 81.2 %
Proportion of births in study 4.8 % 10.6 % 15.4 % 84.6 % 100.0 %
Eligibility status at consent often differed from eligibility status at original screening because of a delay in implementing preconception enrollment. Of the 970
enrolled pregnant, 228 were not pregnant at initial screening. See Fig. 1 and reference #11
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cumulative probability of conception was significantly
different between the groups (p < 0.001, log rank test).
Timeliness of study visit near conception
Of the 165 women enrolled preconception who became
pregnant, 161 had dates of conception obtainable from
ultrasound; 137 (85 %) of these had a record of complet-
ing a preconception visit. (Of the 24 women who were
not known to complete a preconception visit, 18 had a
conception date after September 2010, i.e., after the
change in study data systems, a time frame for which we
did not have data regarding study visits available.) As
shown in Table 3, only 19 % of these visits took place
within 30 days before or after the estimated date of con-
ception. Expanding to 90 days before to 30 days after
conception, the proportions are still well less than half:
overall 33 %, high tryers 38 %, high non-tryers 22 %.
Overall, 39 % occurred more than 90 days prior to con-
ception. Finally, 13 % occurred more than 30 days after
conception.
Timeliness of first pregnancy study visit
We also examined the time from conception to the first
home study visit during pregnancy, in relation to the
type of study eligibility at the time of consent (Fig. 3). By
10.5 weeks (74 days) after conception, 75 % of women
enrolled preconception had completed a home study
visit; for women enrolled pregnant, the 75 % threshold
was not reached until 28.3 weeks (198 days) after con-
ception. The time to first pregnancy study visit was sig-
nificantly different between the groups (p < 0.001, log
rank test). However, among the women enrolled precon-
ception, there was no difference in time to first preg-
nancy visit between the high tryers and the high non-
tryers (data not shown).
Discussion
The Initial Vanguard Centers of the National Children’s
Study enrolled 1399 women, 429 preconception (198
trying for pregnancy, and 231 not trying) and 970
already pregnant, resulting ultimately in 922 births. Pre-
conception women represented 30.6 % of women en-
rolled, and contributed 14.5 % of births. Among women
Table 2 Age and race/ethnicity of women giving birth in the









Age, years <18 0 0 1.4
18–19 * 0 3.3
20–34 90.9 83.7 76.5
35+ * 16.3 18.7
Mean (standard deviation) 27.7 (4.0) 30.7 (4.1) 29.2 (5.7)
Race/ethnicity Asian, non-Hispanic * * 4.2
Black, non-Hispanic * * 6.4
Hispanic 22.7 10.2 20.0
Other^ 20.5 20.4 8.0
White, non-Hispanic 50.0 67.3 61.5
*Cell counts are too small to display. (Despite age eligibility criteria for high
non-tryers, the cell counts for age 35+ are not zero)
^includes women who report two or more races. For age categories, P < 0.05; For
race and ethnicity, P < 0.01
Fig. 2 Time from screening to conception by pregnancy probability
group (High Tryer versus High Non-Tryer) at initial screening, adjusted
for loss to follow-up. Shading represents 95 % confidence interval
Table 3 Time interval from preconception study visit to
conception, by eligibility status at the time of consent (n = 161)a
Time interval relative to
conception
High non-tryer High tryer All preconception
% % %
More than 90 days before
conception
51.9 32.7 39.1
31 to 90 days before
conception
9.3 16.8 14.3
30 days before or after
conception
13.0 21.5 18.6






Total 100 100 100
aThe table excludes four women with an unknown estimated date of conception
b11 % of all preconception women had a conception date after August 2010,
a time period for which data on study visits was not available
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who gave birth, and who had enrolled preconception
trying for pregnancy, 67.3 % were white non-Hispanic,
compared to 50.0 % of preconception women giving
birth who enrolled not trying for pregnancy. Women en-
rolled preconception who were trying for pregnancy had
higher cumulative probability of pregnancy at one year
compared to women not trying (adjusted 86 % versus
56 %). Of 165 women enrolled preconception who be-
came pregnant, 19 % had a study visit within 30 days
before or after conception. By 10.5 weeks after concep-
tion, 75 % of women enrolled preconception had com-
pleted a pregnancy study visit; for women enrolled
pregnant, the 75 % threshold was reached at 28.4 weeks.
These results provide important insights for future
preconception cohort studies with regard to the propor-
tion of births ultimately enrolled for women enrolled
preconception, demographic characteristics of women
enrolled trying or not trying for pregnancy, the time to
live birth for women enrolled trying or not trying to
conceive, and the timeliness of exposure assessments
around conception or in early pregnancy. We discuss
each of these in turn below.
Yield and retention
Although approximately one third (31 %) of the women
enrolled into the NCS enrolled with preconception sta-
tus, these women contributed 15 % of the births in the
study, with the drop being related to the proportion of
preconception women actually conceiving. Because the
preconception enrollment part of the protocol was not
implemented until nearly a year after the study recruit-
ment began, some of the women who would have been
eligible for preconception enrollment early on were in-
stead enrolled later as already pregnant (see Fig. 1, and
Table 1, footnote). Therefore the proportion of births
from preconception women would most likely have been
higher if the preconception enrollment had been imple-
mented from the beginning.
Pregnancy loss was specifically documented for 34
pregnancies (3.0 %), while the incidence of clinically rec-
ognized spontaneous abortion in normal pregnancy has
been reported at 12–16 % [13, 14]. This strongly sug-
gests that loss was under-ascertained in the follow-up.
The data did not allow us to identify what proportion of
women who did not proceed to live birth had a preg-
nancy loss, moved, or were lost to follow-up. However,
the combined retention rates were about the same for all
pregnant women, regardless of how they were enrolled,
mitigating any concern for selection bias resulting from
differential retention. We consider this rate of retention
to be good, given the high mobility of pregnant women.
In prior population-based studies in North America,
from 12 to 25 % changed residence during pregnancy
[15, 16].
Demographic characteristics by type of eligibility
at consent
Of women giving birth who were enrolled preconception
and trying for pregnancy, 67.3 % were white non-Hispanic
and 10.2 % Hispanic, compared to preconception women
not trying for pregnancy (but heterosexually active and at
substantial risk for pregnancy), among whom 50 %
were white non-Hispanic and 22.7 % Hispanic (Table 2).
Among women who were enrolled pregnant, 61.5 %
were white non-Hispanic and 20.0 % Hispanic pregnant
women. This is consistent with national U.S. data
showing higher proportions of unintended pregnancies
among most racial and ethnic minorities [17].
Time to pregnancy among preconception women
Women who reported they were trying for pregnancy
for less than 5 months (high tryers) had cumulative
pregnancy rates quite similar to other studies of time to
pregnancy in couples without known subfertility, i.e.,
86 % at 1 year, adjusting for loss to follow up [18, 19].
Because about half of pregnancies in the United States
are reported as unintended [17], the study protocol
attempted also to identify those at risk of pregnancy
who are not planning pregnancy. The rates of transition
to pregnancy among the high non-tryers found in the
initial vanguard cohort of the NCS were somewhat lower
than in the women trying to become pregnant (56 % at
one year versus 86 %, adjusting for loss to follow up).
This is not surprising given the criteria used to classify
Fig. 3 Time from conception to first pregnancy study visit by type
of enrollment, adjusted for exiting from study (due to change in
eligibility, withdrawal, pregnancy loss, or loss to follow-up). Shading
represents 95 % confidence interval
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women as high non-tryers. For example, users of trad-
itional calendar rhythm or withdrawal have average first
year pregnancy rates of 25 % or less [20]. In older na-
tional data, married women who reported intercourse
within the last 3 months, no contraceptive use, and no
intention to get pregnant had first year pregnancy rates
of 57 % or less [21]. Anecdotally, many of the women in
the high non-tryer group questioned why they were eli-
gible for preconception enrollment, when they did not
consider themselves likely to get pregnant. Yet, over half
of this group of women did conceive within a year.
Timeliness of study visit near conception
One of the reasons for preconception enrollment was to
conduct a detailed preconception study assessment in
the home, including collecting environmental samples,
biological samples, and questionnaires. We were disap-
pointed to find that so few of the the preconception
study visits were conducted close to the time of concep-
tion: among 165 women enrolled preconception who
became pregnant, only 19 % had a study visit within
30 days before or after conception. About a third (33 %)
of visits were conducted within 90 days before to 30 days
after the date of conception. This proportion was
greater for high tryers (38 %) than for high non-tryers
(22 %). As noted below, some of the logistics of schedul-
ing likely influenced the timeliness of preconception
study visits.
Timeliness of first pregnancy study visit
Women enrolled preconception were very likely to
complete first study visits during pregnancy in a timely
manner, much more so than women enrolled during preg-
nancy. By 10.5 weeks after conception (12.5 weeks gesta-
tion age), 75 % of women enrolled preconception had
completed a home study visit; for women enrolled preg-
nant, the 75 % threshold was not reached until 28.3 weeks
after conception (30.3 weeks gestational age). This oc-
curred despite the fact that the study was designed to facili-
tate enrollment as early in pregnancy as possible, and that
during the first approximately 3 months of study recruit-
ment, pregnant women had to be with the first 20 weeks
of pregnancy to be eligible for the study. The fact that
women enrolled preconception had an earlier identification
of their pregnancy to study staff facilitated the scheduling
of an early study visit.
Challenges in scheduling study visits
The structure of the study included a number of challenges
for scheduling study visits. The staff for enumeration and
consent were typically different from the staff for the study
visits, and the training for each was role-specific. Ini-
tially, different information systems with different
field devices were used for enumeration and consent
than for study visits. Home study visits were often
scheduled on evenings or weekends, to adapt to partici-
pant schedules. Calendars needed to be orchestrated for
the availability of the personnel and equipment required
for each visit.
Pregnancy status was assessed explicitly by questions
within the initial screening, and at scheduled follow-up
phone calls, as described above. However, study instru-
ments did not include questions addressing current
pregnancy status at the time of scheduling for the pre-
conception visit, nor during the preconception visit it-
self; also a urine pregnancy test was not part of the
preconception visit. Despite this potential delay in iden-
tifying pregnancy among the women enrolled precon-
ception, they still had their first home study visit earlier
than women enrolled during pregnancy.
Limitations
Our analysis is limited by the transition of the Initial
Vanguard Centers to new, decentralized data systems
that occurred after September 2010. We did not have ac-
cess to any information regarding study visits after the
transition in data systems. For women exiting the study
prior to a live birth, we did not have systematic data on
whether the exit was due to a pregnancy loss, a known
move, or simply a loss to follow up.
Strengths
The Initial Vanguard Centers successfully conducted a
rich and complex implementation of the protocol for the
initial vanguard cohort of the NCS. The sampling frame
was well defined. In fact, other Vanguard Centers have
reported on more specific comparisons of participants
to births within study SSUs based on birth certificates
[22]. The rich characterization of both high tryers and
high non-tryers provides valuable insight into the
characterization and follow up of a population-based
sample of women at higher risk of pregnancy.
Rationale for early exposure assessment
Animal and human studies indicate that exposures in
the earliest stages of human development, including the
embryonic and early fetal periods, may have a large
impact on subsequent development, health and illness
throughout the lifespan [23–26], and that the impact of
some exposures may be transgenerational by epigenetic
mechanisms [27]. Based on this rationale, a number of
scientists proposed assessing environmental exposure
as early in pregnancy as possible, including preconcep-
tion and periconceptional periods [28–30]. Because of
time-varying components of some exposures, there is
high value in conducting such assessment prospectively.
For these reasons, the initial vanguard cohort of the NCS
was designed to enroll women as early in pregnancy as
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possible, and also to enroll some women who were not
currently pregnant, but at high probability of becom-
ing pregnant in the near future [8]. The importance of
timing in exposure assessment will of course vary ac-
cording to a number of factors involved for each spe-
cific exposure, including the likelihood of change of
level in a specific exposure over time before and/or
after conception, the developmental window of interest
for the exposure, and the reliability of measuring the
exposure at different time points retrospectively or
perhaps prospectively in relation to the time window
of interest.
Competing priorities
In recent years, there has been a flourishing of new birth
cohorts, as well as new data from long-established birth
cohorts, seeking to address questions regarding early life
course exposures and the developmental origins of
childhood and adult disease [31, 32]. Before discontinu-
ation of the NCS, there was extensive discussion of the
best way to realize its potential, including recommenda-
tions to abandon preconception recruitment [10, 33],
maintain preconception recruitment to the extent pos-
sible [34], maintain probability-based household sam-
pling [35], move to provider-based sampling [22, 36],
focus on explicit hypotheses for important diseases of
low incidence [37], and so on. All such suggestions in-
volve choices and trade-offs between competing prior-
ities and the impact of different types of recruitment for
any birth cohort study [38, 39]. Our analysis provides
data informing some of these competing priorities in ref-
erence to assessment of peri-conception and early preg-
nancy exposures.
To the extent that the goal for a pregnancy and birth co-
hort study may be robust preconception exposure assess-
ment in an efficient manner, a logical focus would be on
recruiting women or couples trying for pregnancy, while
still maintaining a population-based sampling frame. This
could be done while considering more cost-effective
recruiting mechanisms than door-to-door recruitment, in-
cluding mail or internet [30, 40], more streamlined pre-
conception exposure assessment, as well as innovative
low-cost approaches to identifying the preconception
period [41, 42]. There is a trade-off that women trying to
conceive are demographically significantly different than
other women who conceive without “trying”, which may
limit external generalizability.
Our results also suggest that preconception recruit-
ment can help achieve the goal of exposure assessment
early in pregnancy, more so than recruitment during
pregnancy. With regard to the timing of the first study
visit in pregnancy, the experience of high tryers and high
non-tryers was identical, suggesting that the decision of
whether to include high non-tryers in a cohort would
have to weigh representativeness against efficiency and
resources.
Provider-based sampling and recruitment, while pre-
senting a number of valuable efficiencies and retaining
overall representativeness [36, 43], may present chal-
lenges for early exposure assessment. Women in the
United States do not obtain prenatal care as early as in
other countries that have conducted pregnancy cohorts
[44, 45]. Minority women and women who are less com-
pliant with medical procedures present substantially
later for prenatal care [45–47]. In the United States, pre-
conception care from providers is recommended to be
integrated into primary care for both women and men,
but there are no measures to identify the extent to
which this is happening, or to which provider based
sampling could be effectively used for preconception re-
cruitment [48].
Finally, pregnancy to birth cohort studies should care-
fully track pregnancy outcomes other than live birth, not
only to understand the reasons for attrition, but also be-
cause a complete analysis and understanding of the impact
of environmental exposures on early human development
requires the inclusion of human developmental outcomes
other than live birth [49, 50].
Conclusions
The Initial Vanguard Centers of the U.S. National
Children’s Study successfully recruited and enrolled
1399 women in pregnancy (69 %) or preconception
(31 %), while exploring many of the competing prior-
ities and difficult decisions that need to be addressed
in future research. These data confirm that there are im-
portant demographic differences in births from women
who try to conceive and women who do not try to con-
ceive; and that it is possible to enroll and follow women
preconception who are at substantial risk of pregnancy,
despite the fact that they are not trying to conceive. While
time to pregnancy is shorter for women actively trying for
pregnancy, approximately half of women who are not try-
ing but are at substantial risk for pregnancy conceive
within a year. In the context of the protocol for the initial
vanguard cohort of the NCS, most women enrolled pre-
conception did not have exposure assessment within
30 days of conception, but they did have exposure assess-
ment much earlier during pregnancy than women who
enrolled during pregnancy.
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